01.09.2021 Limes Schlosskliniken AG  DE000A0JDBC7

DGAP-Adhoc: Limes Schlosskliniken AG: Positive Business Results in the First Half Year 2021


 

DGAP-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Half Year Results/Development of Sales
Limes Schlosskliniken AG: Positive Business Results in the First Half Year 2021

01-Sep-2021 / 14:40 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


DGAP-Adhoc: Limes Schlosskliniken AG:

Positive business development in the first half year 2021

Key word: Half-Year Report 2021

- Total revenue EUR 8,2 million (p.y. EUR 4,6 million) +78,5 %

- Patient days 15.525 (p.y. 9.721) + 59,7 %

- Gross earnings (EBITDA) +2.278 kEUR (p.y. +15 kEUR)

- EBITDA-Margin 27,9 % (p.y. 0,3 %)

- Operating result (EBIT) + 1.675 kEUR (p.y. -509 kEUR)

- Result for shareholders of the parent company + 1.552 kEUR (p.y. -645 kEUR)

- Earning per share EUR + 5,29 (p.y. EUR -2,20)

- Positive business development expected to continue in second half year, good financial resources

 

Köln, September 01, 2021: The LIMES Schlosskliniken Group registered a very positive business performance in the first six months. Both clinics contributed to this result through good occupancy rates. Due to the positive patient response, we were able to significantly increase our occupancy rate.

Despite the difficult conditions caused by Covid-19 the clinic Mecklenburgische Schweiz was again able to expand revenue by +11% to a total of EUR 5 million in the first half of 2021. We expect the positive trend to continue in the second half of the year.

Our new clinic in Bad Brückenau already achieved revenue of EUR 3.2 million in the first half of the year. Occupancy rate is developing according to plan.

The start-up of the third LIMES Schlossklinik Bergisches Land located near Cologne is currently being prepared. The aim is to start clinic operations in the second quarter of 2022. We have approved the architectural designs for the construction of a fourth clinic.

The detailed Half-Year Report of LIMES Schlosskliniken Group will be published on 20.09.2021.


Short company profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.

Your contact person:
Limes Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Köln
Tel.: 02203 / 29014-202, [email protected], www.limes-schlosskliniken.de

Language: English
Company: Limes Schlosskliniken AG
Kaiser-Wilhelm-Ring 26
50672 Köln
Germany
Tele.: 49 2203 29014-202
Fax: 49 2203 29014-201
Email: [email protected]
Internet: www.limes-schlosskliniken.de
ISIN: DE000A0JDBC7
WKN: AOJDBC
Stock exchange Düsseldorf Freiverkehr, Primärmarkt, XETRA

End of the message

 


01-Sep-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Limes Schlosskliniken AG
Kaiser-Wilhelm-Ring 26
50672 Köln
Germany
ISIN: DE000A0JDBC7
WKN: A0JDBC
Listed: Regulated Unofficial Market in Dusseldorf
EQS News ID: 1230467

 
End of Announcement DGAP News Service

1230467  01-Sep-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1230467&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 6,54 7,43 8,18 11,02 16,90 27,00
EBITDA1,2 0,00 -0,49 -0,13 0,26 0,84 5,39 7,60
EBITDA-Marge3 0,00 -7,49 -1,75 3,18 7,62 31,89 28,15
EBIT1,4 0,00 -0,72 -0,93 -0,54 -0,43 3,51 5,40
EBIT-Marge5 0,00 -11,01 -12,52 -6,60 -3,90 20,77 20,00
Jahresüberschuss1 0,00 -1,25 -1,46 -0,83 -0,69 3,10 3,80
Netto-Marge6 0,00 -19,11 -19,65 -10,15 -6,26 18,34 14,07
Cashflow1,7 0,00 1,02 -0,66 0,17 0,76 4,90 6,40
Ergebnis je Aktie8 0,00 -4,95 -5,78 -2,81 -2,37 10,55 12,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: B-S-H Collegen

XETR:LIK Charts by TradingView (c)


INVESTOR-INFORMATIONEN
©boersengefluester.de
Limes Schlosskliniken
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0JDBC 228,000 Kaufen 66,85
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
15,20 19,26 0,81 -287,88
KBV KCV KUV EV/EBITDA
15,80 88,07 3,96 13,14
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 10.06.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
15.09.2022 16.05.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
7,56% 28,17% 10,68% 115,09%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Limes Schlosskliniken AG  ISIN: DE000A0JDBC7 können Sie bei DGAP abrufen


Pflegeeinrichtungen , A0JDBC , LIK , XETR:LIK